Inguinal hernias - epidemiology, mosquito nets and cost effectiveness

ISRCTN ISRCTN20596933
DOI https://doi.org/10.1186/ISRCTN20596933
Secondary identifying numbers 2012/1
Submission date
09/01/2012
Registration date
16/02/2012
Last edited
10/04/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
An inguinal hernia occurs when fatty tissue or a part of the bowel pokes through into the groin. They are usually painful and may occasionally even cause death. Surgical repair of inguinal hernias is one of the most common procedures in sub-Saharan Africa. In high-income countries, the repair is usually done with a plastic mesh. It has been proven many times to be vastly superior to non-mesh repair methods. In low- and middle-income countries, these meshes are almost always too expensive for most people, who are therefore treated by outdated methods with a poor outcome. The use of locally available sterilized mosquito nets in hernia repair appears to be a promising alternative. The aim of this study is to find out whether the use of commercial mesh and mosquito nets are comparable in terms of outcome.

Who can participate?
Men aged over 18 with an inguinal hernia.

What does the study involve?
Participants are randomly allocated to have a hernia repair using either a standard commercial mesh or a sterilized mosquito net of similar size. They are followed for at least a year to see if there is any difference in complications, pain and recurrence between the groups. We also calculate the cost-effectiveness of these two forms of hernia repair.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Karolinska Institute (Sweden)

When is the study starting and how long is it expected to run for?
February 2012 to June 2014

Who is funding the study?
Swedish Medical Society, Karolinska Institute, Golje Foundation and Capio Foundation (Sweden).

Who is the main contact?
Dr Andreas Wladis
awladis@gmail.com

Contact information

Dr Andreas Wladis
Scientific

Karolinska Institute
St Göran's Hospital
St Göransplan 1
Stockholm
112 81
Sweden

Email awladis@gmail.com

Study information

Study designDouble-blind randomized controlled clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleInguinal Hernia Surgery in Uganda [IHSIU) - a randomized clinical trial comparing commercial mesh and mosquito net in the Lichtenstein Repair of Uncomplicated Inguinal Hernia in the Iganga-Mayuge demographic surveillance site in Uganda
Study acronymIHSIU
Study hypothesisIn open, surgical repair of primary inguinal hernias, the use of commercial mesh and mosquito nets are comparable in terms postoperative outcome and different only with regard to cost.
Ethics approval(s)Makerere University, Kampala, Uganda, 05/10/2011, ref: SBSC 006
ConditionPrimary inguinal hernias
InterventionPatients will be randomized to have a hernia repair using either a standard commercial mesh or a sterilized mosquito net of similar size
Intervention typeProcedure/Surgery
Primary outcome measure1. Postoperative complications
2. Postoperative pain
3. Hernia recurrence
4. Cost-effectiveness
Secondary outcome measuresQuality of life
Overall study start date06/02/2012
Overall study end date27/06/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexMale
Target number of participants380
Participant inclusion criteria1. Age > 18 years
2. Male
3. Reducible, unilateral, primary, inguinal hernia
4. The patient accepts participation and gives informed consent
Participant exclusion criteria1. Female
2. Recurrent hernia
3. Femoral hernia
4. Ongoing anticoagulant medication
5. Current drug abuse
6. ASA group 3 and above
Recruitment start date06/02/2012
Recruitment end date27/06/2014

Locations

Countries of recruitment

  • Sweden
  • Uganda

Study participating centre

Karolinska Institute
Stockholm
112 81
Sweden

Sponsor information

Swedish Medical Society (Sweden)
Research organisation

PO Box 738
Stockholm
10135
Sweden

Phone +46 (0)8 790 33 00
Email info@sls.se
Website http://www.slf.se/Info-in-English/
ROR logo "ROR" https://ror.org/016ks4x90

Funders

Funder type

Research organisation

Swedish Medical Society (Sweden)

No information available

Karolinska Institutet
Government organisation / Local government
Alternative name(s)
Karolinska Institute, KI
Location
Sweden
Golje Foundation (Sweden)

No information available

Capio Foundation (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 14/01/2016 Yes No
Results article cost-effectiveness results 01/05/2017 Yes No

Editorial Notes

10/04/2025: Internal review.
17/02/2017: Publication reference added.
14/01/2016: Publication reference added.